Cytokine and Chemokine Profiles in COVID-19: Why Did Conventional Inflammatory Markers Outperform Cytokines?
Eurasian Journal of Medical Advances · 2025 · 153-161
DOI: 10.14744/ejma.267153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2025. Verfasst von Onur Alkan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The Eurasian Journal of Medical Advances (EJMA) is an open access, double-blind peer-reviewed medical journal publishing qualified research across all medical investigations. The journal is published quarterly in March, June, September and December.
Zitieren
APA
Alkan, O., Şenkal, N., Medetalibeyoğlu, A., & Köse, M. (2025). Cytokine and Chemokine Profiles in COVID-19: Why Did Conventional Inflammatory Markers Outperform Cytokines?. Eurasian Journal of Medical Advances, 153-161. https://doi.org/10.14744/ejma.267153
Vancouver
Alkan O, Şenkal N, Medetalibeyoğlu A, Köse M. Cytokine and Chemokine Profiles in COVID-19: Why Did Conventional Inflammatory Markers Outperform Cytokines?. Eurasian Journal of Medical Advances. 2025:153-161. doi:10.14744/ejma.267153
BibTeX
@article{Alkan2025,
author = {Alkan, Onur and Şenkal, Naci and Medetalibeyoğlu, Alpay and Köse, Murat},
title = {Cytokine and Chemokine Profiles in COVID-19: Why Did Conventional Inflammatory Markers Outperform Cytokines?},
journal = {Eurasian Journal of Medical Advances},
year = {2025},
pages = {153--161},
doi = {10.14744/ejma.267153}
}
EUVIMED